1. Heideman RL, Cole DE, Balis F et al (1989) Phase I and pharmacokinetic evaluation of thiotepa in the cerebrospinal fluid and plasma of pediatric patients: evidence for dose-dependent plasma clearance of thiotepa. Cancer Res 49:736–741
2. Friedman HS, Colvin OM, Skapek SX et al (1988) Experimental chemotherapy of human medulloblastoma cell lines and transplantable xenografts with bifunctional alkylating agents. Cancer Res 48:4189–4195
3. Tartaglia RL, Cole DE, Heideman RL (1989) Chemosensitivity of central nervous system tumors to thiotepa and tepa. Proc Am Assoc Cancer Res 30:461
4. Schold SC Jr, Friedman HS, Bigner DD (1987) Therapeutic profile of the human glioma line D-54 MG in athymic mice. Cancer Treat Rep 71:849–850
5. Dunkel IJ, Boyett JM, Yates A et al (1998) High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children’s Cancer Group. J Clin Oncol 16:222–228